The chemical and pharmaceutical companies protect their investment in research and development and future business with the acquisition of patents on their inventions. The success or failure often depends on the strength of the patent or its ability to withstand competition.
Recently, the United States Patent and Trademark Office, changes to the patents will be treated, proposed to reduce the workload of patent examiners. These changes could drastically limit the ability of the Company to obtain strong patents. Under current practice, if the company is not satisfied with the examiner’s refusal to grant a patent, the company can be a file, put two or more patent applications, so that trade can further between the applicant and the examiner.
If the proposed changes are permanent, and is widely expected they will, the patent applicant in a position to be a single continuation application, which means that only a limited number of exchanges are possible, submit the form. If these talks do not lead to a patent, but the applicant may the scope of the invention by further distancing of the invention of a language of known drugs have reduced or lost in some cases be quite patent.
If the patent applicant to amend or restrict the application looks, he can be a number of legal obstacles. For example, the examiner as saying that the application as filed does not contain language that will refuse to change the applicant’s request. To avoid this unfavorable result, the patent application have prepared so that the examiner can not reject the change.
To illustrate, consider the following situation where the candidate describes his invention, which is a drug formulation with a drug in an amount of 1 to 50%. The auditor has to sign up for a drug formulation is known to 7%. If the patent application had passed only 10-50% of the drugs that can modify the application of the inventors not to say 8-50% to avoid the formulation known. On the other hand, when a cascade of fallback positions was in use at the time of patenting, such as 5-30%, 10-20% and 12-15% have been recorded, it can then modify the application by 10-30 % or 10-20% of the drugs to his invention, the medication of 11% can cover. In the absence of a fallback position, the applicant will lose the entire patent.
A patent is a legal document seriously and should be prepared with great care. This requires knowledge of the industry, for example, what was done before and that competition is trying to circumvent the patent. As a result of the proposed regulations, the importance of writing a good patent can not be overstated.
